Mesotherapy for local fat reduction
Summary Mesotherapy, which is the injection of substances locally into mesodermally derived subcutaneous tissue, developed from empirical observations of a French physician in the 1950s. Although popular in Europe for many medical purposes, it is used for local cosmetic fat reduction in the United S...
Gespeichert in:
Veröffentlicht in: | Obesity reviews 2013-10, Vol.14 (10), p.780-791 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 791 |
---|---|
container_issue | 10 |
container_start_page | 780 |
container_title | Obesity reviews |
container_volume | 14 |
creator | Jayasinghe, S. Guillot, T. Bissoon, L. Greenway, F. |
description | Summary
Mesotherapy, which is the injection of substances locally into mesodermally derived subcutaneous tissue, developed from empirical observations of a French physician in the 1950s. Although popular in Europe for many medical purposes, it is used for local cosmetic fat reduction in the United States. This paper reviews manuscripts indexed in PubMed/MEDLINE under ‘mesotherapy’, which pertains to local fat reduction. The history of lipolytic mesotherapy, the physiology of body fat distribution, the mechanism of action of different lipolytic stimulators and their increased efficacy in combination are reviewed. Mesotherapy falls into two categories. Lipolytic mesotherapy using lipolytic stimulators requires more frequent treatments as the fat cells are not destroyed and can refill over time. Ablative mesotherapy destroys fat cells with a detergent, causes inflammation and scarring from the fat necrosis, but requires fewer treatments. The historic and empiric mixing of sodium channel blocking local anaesthetics in mesotherapy solutions inhibits the intended lipolysis. Major mesotherapy safety concerns include injection site infections from poor sterile technique. Cosmetic mesotherapy directs the area from which fat is lost to improve self‐image. Studies were of relatively small number, many with limited sample sizes. Future research should be directed towards achieving a Food and Drug Administration indication rather than continuing expansion of off‐label use. |
doi_str_mv | 10.1111/obr.12049 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1432618207</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3069238671</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3919-3b31df74842266ac3a62e4854a01914d92975e012a486c524e603da3b3a099553</originalsourceid><addsrcrecordid>eNp1kEFPwjAYhhujEUUP_gGzhIseBv3arluPShRNUBKDyK0pWxeHg2K7Rfn3FgccTOzl6-F5n-_Li9AF4C741zMz2wWCmThAJ8B4HMaJmB7u_wm00Klzc4whFhSOUYvQBGPCxQnqPGlnqndt1Wod5MYGpUlVGeSqCqzO6rQqzPIMHeWqdPp8O9vo9f5u3H8Ih6PBY_9mGKZUgAjpjEKWxyxhhHCuUqo40SyJmMIggGWCiDjSGIhiCU8jwjTHNFM-prAQUUTb6Krxrqz5rLWr5KJwqS5LtdSmdhIYJRwSgmOPdv6gc1Pbpb9uQ0HE_QrsqeuGSq1xzupcrmyxUHYtActNc9I3J3-b8-zl1ljPFjrbk7uqPNBrgK-i1Ov_TXJ0-7JThk2icJX-3ieU_ZA8pnEk354HcjIeJhNgU8noD0hhgsQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1431564860</pqid></control><display><type>article</type><title>Mesotherapy for local fat reduction</title><source>Wiley Online Library - AutoHoldings Journals</source><source>MEDLINE</source><creator>Jayasinghe, S. ; Guillot, T. ; Bissoon, L. ; Greenway, F.</creator><creatorcontrib>Jayasinghe, S. ; Guillot, T. ; Bissoon, L. ; Greenway, F.</creatorcontrib><description>Summary
Mesotherapy, which is the injection of substances locally into mesodermally derived subcutaneous tissue, developed from empirical observations of a French physician in the 1950s. Although popular in Europe for many medical purposes, it is used for local cosmetic fat reduction in the United States. This paper reviews manuscripts indexed in PubMed/MEDLINE under ‘mesotherapy’, which pertains to local fat reduction. The history of lipolytic mesotherapy, the physiology of body fat distribution, the mechanism of action of different lipolytic stimulators and their increased efficacy in combination are reviewed. Mesotherapy falls into two categories. Lipolytic mesotherapy using lipolytic stimulators requires more frequent treatments as the fat cells are not destroyed and can refill over time. Ablative mesotherapy destroys fat cells with a detergent, causes inflammation and scarring from the fat necrosis, but requires fewer treatments. The historic and empiric mixing of sodium channel blocking local anaesthetics in mesotherapy solutions inhibits the intended lipolysis. Major mesotherapy safety concerns include injection site infections from poor sterile technique. Cosmetic mesotherapy directs the area from which fat is lost to improve self‐image. Studies were of relatively small number, many with limited sample sizes. Future research should be directed towards achieving a Food and Drug Administration indication rather than continuing expansion of off‐label use.</description><identifier>ISSN: 1467-7881</identifier><identifier>EISSN: 1467-789X</identifier><identifier>DOI: 10.1111/obr.12049</identifier><identifier>PMID: 23800269</identifier><language>eng</language><publisher>England: Blackwell Publishing Ltd</publisher><subject>Adipocytes - metabolism ; Cosmetic ; Europe ; fat necrosis ; Humans ; Injections, Subcutaneous - adverse effects ; Injections, Subcutaneous - methods ; lipolysis ; Lipolysis - physiology ; Mesotherapy - adverse effects ; Mesotherapy - methods ; Obesity - therapy ; Subcutaneous Fat - metabolism ; United States</subject><ispartof>Obesity reviews, 2013-10, Vol.14 (10), p.780-791</ispartof><rights>2013 The Authors. reviews © 2013 International Association for the Study of Obesity</rights><rights>2013 The Authors. obesity reviews © 2013 International Association for the Study of Obesity.</rights><rights>Obesity Reviews © 2013 International Association for the Study of Obesity</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3919-3b31df74842266ac3a62e4854a01914d92975e012a486c524e603da3b3a099553</citedby><cites>FETCH-LOGICAL-c3919-3b31df74842266ac3a62e4854a01914d92975e012a486c524e603da3b3a099553</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fobr.12049$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fobr.12049$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,27915,27916,45565,45566</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23800269$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jayasinghe, S.</creatorcontrib><creatorcontrib>Guillot, T.</creatorcontrib><creatorcontrib>Bissoon, L.</creatorcontrib><creatorcontrib>Greenway, F.</creatorcontrib><title>Mesotherapy for local fat reduction</title><title>Obesity reviews</title><addtitle>Obes Rev</addtitle><description>Summary
Mesotherapy, which is the injection of substances locally into mesodermally derived subcutaneous tissue, developed from empirical observations of a French physician in the 1950s. Although popular in Europe for many medical purposes, it is used for local cosmetic fat reduction in the United States. This paper reviews manuscripts indexed in PubMed/MEDLINE under ‘mesotherapy’, which pertains to local fat reduction. The history of lipolytic mesotherapy, the physiology of body fat distribution, the mechanism of action of different lipolytic stimulators and their increased efficacy in combination are reviewed. Mesotherapy falls into two categories. Lipolytic mesotherapy using lipolytic stimulators requires more frequent treatments as the fat cells are not destroyed and can refill over time. Ablative mesotherapy destroys fat cells with a detergent, causes inflammation and scarring from the fat necrosis, but requires fewer treatments. The historic and empiric mixing of sodium channel blocking local anaesthetics in mesotherapy solutions inhibits the intended lipolysis. Major mesotherapy safety concerns include injection site infections from poor sterile technique. Cosmetic mesotherapy directs the area from which fat is lost to improve self‐image. Studies were of relatively small number, many with limited sample sizes. Future research should be directed towards achieving a Food and Drug Administration indication rather than continuing expansion of off‐label use.</description><subject>Adipocytes - metabolism</subject><subject>Cosmetic</subject><subject>Europe</subject><subject>fat necrosis</subject><subject>Humans</subject><subject>Injections, Subcutaneous - adverse effects</subject><subject>Injections, Subcutaneous - methods</subject><subject>lipolysis</subject><subject>Lipolysis - physiology</subject><subject>Mesotherapy - adverse effects</subject><subject>Mesotherapy - methods</subject><subject>Obesity - therapy</subject><subject>Subcutaneous Fat - metabolism</subject><subject>United States</subject><issn>1467-7881</issn><issn>1467-789X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kEFPwjAYhhujEUUP_gGzhIseBv3arluPShRNUBKDyK0pWxeHg2K7Rfn3FgccTOzl6-F5n-_Li9AF4C741zMz2wWCmThAJ8B4HMaJmB7u_wm00Klzc4whFhSOUYvQBGPCxQnqPGlnqndt1Wod5MYGpUlVGeSqCqzO6rQqzPIMHeWqdPp8O9vo9f5u3H8Ih6PBY_9mGKZUgAjpjEKWxyxhhHCuUqo40SyJmMIggGWCiDjSGIhiCU8jwjTHNFM-prAQUUTb6Krxrqz5rLWr5KJwqS5LtdSmdhIYJRwSgmOPdv6gc1Pbpb9uQ0HE_QrsqeuGSq1xzupcrmyxUHYtActNc9I3J3-b8-zl1ljPFjrbk7uqPNBrgK-i1Ov_TXJ0-7JThk2icJX-3ieU_ZA8pnEk354HcjIeJhNgU8noD0hhgsQ</recordid><startdate>201310</startdate><enddate>201310</enddate><creator>Jayasinghe, S.</creator><creator>Guillot, T.</creator><creator>Bissoon, L.</creator><creator>Greenway, F.</creator><general>Blackwell Publishing Ltd</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7TS</scope><scope>C1K</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>201310</creationdate><title>Mesotherapy for local fat reduction</title><author>Jayasinghe, S. ; Guillot, T. ; Bissoon, L. ; Greenway, F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3919-3b31df74842266ac3a62e4854a01914d92975e012a486c524e603da3b3a099553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adipocytes - metabolism</topic><topic>Cosmetic</topic><topic>Europe</topic><topic>fat necrosis</topic><topic>Humans</topic><topic>Injections, Subcutaneous - adverse effects</topic><topic>Injections, Subcutaneous - methods</topic><topic>lipolysis</topic><topic>Lipolysis - physiology</topic><topic>Mesotherapy - adverse effects</topic><topic>Mesotherapy - methods</topic><topic>Obesity - therapy</topic><topic>Subcutaneous Fat - metabolism</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jayasinghe, S.</creatorcontrib><creatorcontrib>Guillot, T.</creatorcontrib><creatorcontrib>Bissoon, L.</creatorcontrib><creatorcontrib>Greenway, F.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Physical Education Index</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Obesity reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jayasinghe, S.</au><au>Guillot, T.</au><au>Bissoon, L.</au><au>Greenway, F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Mesotherapy for local fat reduction</atitle><jtitle>Obesity reviews</jtitle><addtitle>Obes Rev</addtitle><date>2013-10</date><risdate>2013</risdate><volume>14</volume><issue>10</issue><spage>780</spage><epage>791</epage><pages>780-791</pages><issn>1467-7881</issn><eissn>1467-789X</eissn><abstract>Summary
Mesotherapy, which is the injection of substances locally into mesodermally derived subcutaneous tissue, developed from empirical observations of a French physician in the 1950s. Although popular in Europe for many medical purposes, it is used for local cosmetic fat reduction in the United States. This paper reviews manuscripts indexed in PubMed/MEDLINE under ‘mesotherapy’, which pertains to local fat reduction. The history of lipolytic mesotherapy, the physiology of body fat distribution, the mechanism of action of different lipolytic stimulators and their increased efficacy in combination are reviewed. Mesotherapy falls into two categories. Lipolytic mesotherapy using lipolytic stimulators requires more frequent treatments as the fat cells are not destroyed and can refill over time. Ablative mesotherapy destroys fat cells with a detergent, causes inflammation and scarring from the fat necrosis, but requires fewer treatments. The historic and empiric mixing of sodium channel blocking local anaesthetics in mesotherapy solutions inhibits the intended lipolysis. Major mesotherapy safety concerns include injection site infections from poor sterile technique. Cosmetic mesotherapy directs the area from which fat is lost to improve self‐image. Studies were of relatively small number, many with limited sample sizes. Future research should be directed towards achieving a Food and Drug Administration indication rather than continuing expansion of off‐label use.</abstract><cop>England</cop><pub>Blackwell Publishing Ltd</pub><pmid>23800269</pmid><doi>10.1111/obr.12049</doi><tpages>12</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1467-7881 |
ispartof | Obesity reviews, 2013-10, Vol.14 (10), p.780-791 |
issn | 1467-7881 1467-789X |
language | eng |
recordid | cdi_proquest_miscellaneous_1432618207 |
source | Wiley Online Library - AutoHoldings Journals; MEDLINE |
subjects | Adipocytes - metabolism Cosmetic Europe fat necrosis Humans Injections, Subcutaneous - adverse effects Injections, Subcutaneous - methods lipolysis Lipolysis - physiology Mesotherapy - adverse effects Mesotherapy - methods Obesity - therapy Subcutaneous Fat - metabolism United States |
title | Mesotherapy for local fat reduction |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T19%3A50%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Mesotherapy%20for%20local%20fat%20reduction&rft.jtitle=Obesity%20reviews&rft.au=Jayasinghe,%20S.&rft.date=2013-10&rft.volume=14&rft.issue=10&rft.spage=780&rft.epage=791&rft.pages=780-791&rft.issn=1467-7881&rft.eissn=1467-789X&rft_id=info:doi/10.1111/obr.12049&rft_dat=%3Cproquest_cross%3E3069238671%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1431564860&rft_id=info:pmid/23800269&rfr_iscdi=true |